Trial Profile

Seizure PRophylaxis IN Glioma (SPRING): a Phase III randomised trial comparing prophylactic Levetiracetam versus no prophylactic antiepileptic drug in patients with newly diagnosed presumed supratentorial glioma

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 07 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Dec 2023 Status changed from recruiting to completed.
11 Jul 2019 Recruitment completion is expected on 15 Aug 2022, according to ISRCTN: Current Controlled Trials
11 Jul 2019 Status changed from not yet recruiting to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com